For many sterile compounding teams, hazardous drug (HD) wipe sampling is one of the most intimidating aspects of USP <800>. Even organizations with strong sterile compounding programs often delay implementation—not because they don’t care about safety, but because they’re unsure what wipe sampling will uncover, how results will be interpreted, or how regulators will respond.

Understand how to design effective media-fill tests that accurately simulate real-world sterile compounding workflows and verify personnel competency across both non-HD and HD environments. This article breaks down the key elements, testing schedules, and documentation practices needed to build a reliable, compliant, and sustainable MFT program.

Explore a focused 90-day roadmap designed to tune up your sterile compounding program without disrupting daily operations. This guide breaks down the essential actions, checks, and habits that drive real, measurable progress toward USP <797> compliance.

Learn how Parasol Medical supports sterile compounders with practical microbiology tools, smarter workflows, and hands-on expertise designed to reduce friction and strengthen compliance. This introductory post outlines who we are, what we offer, and how our approach helps cleanrooms operate more safely, consistently, and inspection-ready every day.